Skip the doc­tor's of­fice? Quest Di­ag­nos­tics pitch­es con­sumer test­ing in new ad cam­paign

3 years ago
Pharma
Marketing

No­var­tis to cut up to 400 jobs at Dublin cam­pus

3 years ago
Pharma

GSK drops com­mer­cial du­ties in Kenya, shifts to dis­trib­u­tor mod­el

3 years ago
Pharma

Man­u­fac­tur­ing roundup: Lon­za to man­u­fac­ture two new FDA-ap­proved ther­a­pies in Hous­ton; Ei­sai fin­ish­es project in ...

3 years ago
Manufacturing

Lin­eage Cell Ther­a­peu­tics opens new Cal­i­for­nia R&D fa­cil­i­ty and ex­pands Is­rael man­u­fac­tur­ing site

3 years ago
Pharma
Cell/Gene Tx

Io­n­is to build new man­u­fac­tur­ing site in South­ern Cal­i­for­nia, dou­bling the size of its cur­rent site

3 years ago
Pharma
Manufacturing

With da­ta from nine-pa­tient study, Vec­tivBio rais­es $125M ahead of lead pro­gram's big read­out

3 years ago
Financing
R&D

J&J and Sanofi-part­nered oral de­liv­ery biotech rais­es $26M on lat­est of­fer­ing

3 years ago
Financing

Bio­Marin heads to FDA with he­mo­phil­ia A gene ther­a­py; Covid-fo­cused biotech signs a small SPAC deal

3 years ago
News Briefing

A Col­orado biotech ends clin­i­cal work to fo­cus on mar­ket­ing AD­HD drug, con­sumer health prod­ucts

3 years ago
R&D

The buck stops ear: Hear­ing loss biotech to look for 's­trate­gic op­tion­s' as da­ta analy­ses prove fruit­less

3 years ago
R&D

New-look Fred Hutch snags slice of Be­zos for­tune for 10 years of re­search

3 years ago
People
Financing

Rel­ma­da re­ports a PhI­II fail, blam­ing 'para­dox­i­cal' place­bo ef­fect — shares wiped

3 years ago
R&D

On Pfiz­er's heels, GSK boasts 'tru­ly ex­cep­tion­al' PhI­II da­ta for RSV vac­cine — mak­ing a bee­line to FDA

3 years ago
R&D
Pharma

Up­dat­ed: Bridge­Bio's $2.4B part­ner­ship takes a sud­den hit as Helsinn plans to with­draw NDA on FGFR2 drug

3 years ago
Deals
R&D

Af­ter bring­ing his to­tal raise for Odyssey to $386M, Gary Glick is ready to start ink­ing deals. Just watch

3 years ago
Financing

Syn­thet­ic com­pletes trans­for­ma­tion with new name and can­cer-killing virus fo­cus

3 years ago
Pharma
Marketing

FDA au­tho­rizes ado­les­cent use of Omi­cron-spe­cif­ic boost­ers

3 years ago
Pharma
Coronavirus

Amid a glob­al build­out, Cy­ti­va ac­quires a provider of vi­ral vec­tor man­u­fac­tur­ing tech­nolo­gies

3 years ago
Deals
Pharma

Look­ing for an ad­van­tage in the crowd­ed SMA space, Roche’s Genen­tech re­leas­es fresh Evrys­di da­ta

3 years ago
R&D
Pharma

AMA, Ad Coun­cil and CDC re­boot flu shot cam­paign for fall

3 years ago
Pharma
Marketing

Vi­a­tris weighs sale of Eu­ro­pean con­sumer health busi­ness — re­port

3 years ago
Deals
Pharma

Ad­di­tion­al man­u­fac­tur­ers in short sup­ply of gener­ic Adder­all

3 years ago
Pharma
Manufacturing

Mod­er­na gets Au­to­lus tar­get­ing tech via li­cens­ing deal; Atai re­ports PhI da­ta for kratom-based ther­a­py

3 years ago
News Briefing
First page Previous page 439440441442443444445 Next page Last page
A service from the Financial Times